Correlation Between Capri Holdings and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Capri Holdings and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capri Holdings and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capri Holdings and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Capri Holdings and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capri Holdings with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capri Holdings and Arcturus Therapeutics.
Diversification Opportunities for Capri Holdings and Arcturus Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Capri and Arcturus is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Capri Holdings and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Capri Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capri Holdings are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Capri Holdings i.e., Capri Holdings and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between Capri Holdings and Arcturus Therapeutics
Given the investment horizon of 90 days Capri Holdings is expected to under-perform the Arcturus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Capri Holdings is 1.15 times less risky than Arcturus Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Arcturus Therapeutics Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 2,494 in Arcturus Therapeutics Holdings on November 28, 2024 and sell it today you would lose (838.00) from holding Arcturus Therapeutics Holdings or give up 33.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Capri Holdings vs. Arcturus Therapeutics Holdings
Performance |
| Timeline |
| Capri Holdings |
| Arcturus Therapeutics |
Capri Holdings and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Capri Holdings and Arcturus Therapeutics
The main advantage of trading using opposite Capri Holdings and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capri Holdings position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.| Capri Holdings vs. Movado Group | Capri Holdings vs. Signet Jewelers | Capri Holdings vs. Lanvin Group Holdings | Capri Holdings vs. TheRealReal |
| Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |